Acorda Therapeutics acorda.com


Public lists: Pharma Startups (4732)

Acorda Therapeutics, a privately held biotechnology company, is developing therapies for spinal cord injury (SCI and related neurological conditions, including multiple sclerosis (MS. The CompanyĆ’-s lead product, Fampridine-SR, is in Phase 3 clinical trials for chronic SCI and Phase 2 for MS. AcordaĆ’-s technology platform includes two remyelinating agents in preclinical development for MS. They include M1, a class of human monoclonal antibodies, and GGF2, a product of the neuregulin 1 gene. Bo...Show all

Acorda Therapeutics, a privately held biotechnology company, is developing therapies for spinal cord injury (SCI and related neurological conditions, including multiple sclerosis (MS. The CompanyĆ’-s lead product, Fampridine-SR, is in Phase 3 clinica...Show all

Company (Alive / Active)

Phone: 914-347-4300

Fax:

420 Saw Mill River Road

Ardsley, 10502
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Acorda Therapeutics $201.5M Oct 6, 2006
See all 24 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Acorda Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 41 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 24 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Water-soluble acetaminophen analogs Mar 22, 2016 May 29, 2018 Patent
Compositions and methods for promoting neuronal outgrowth Jun 10, 2016 May 01, 2018 Patent
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure Oct 30, 2015 May 01, 2018 Patent
Hepatoprotectant acetaminophen mutual prodrugs May 09, 2016 Apr 24, 2018 Patent
Methods of using sustained release aminopyridine compositions Apr 07, 2017 Mar 27, 2018 Patent
See all 110 patents